By Steve Holland, Michael Erman and Patrick Wingrove WASHINGTON (Reuters) -U.S. President Donald Trump signed a wide-reaching executive order on Monday directing drugmakers to lower the prices of their medicines to align with what other countries pay that analysts and legal experts said would be difficult to implement.

The order is based on a "most favored nation" pricing model, which is similar to a policy Trump pushed in his first administration.

President Donald Trump signed an executive order on Monday meant to try to lower drug costs for American consumers. The order, according to a White House official, also sets a 30-day deadline for the health department to broker new price tags for drugs.

President Donald Trump plans to sign an executive order discouraging criminal enforcement of regulatory offenses, in a bid to combat the overcriminalization of federal regulations, a White House official told Reuters on Friday.

President Donald Trump signed three extensive orders -- establishing a national center for homeless veterans, reducing criminal prosecutions for Federal Regulations violating and increasing Federal Register efficiency.